Drugs of abuse
1 / 35

Drugs of abuse - PowerPoint PPT Presentation

  • Uploaded on

Drugs of abuse. Dr B.Vahabi. Drugs of abuse. Learning outcomes Differentiate between drug use and abuse Identify different classes of drugs Explain the mechanism of action by which different drugs mediate their effects.

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about ' Drugs of abuse' - winka

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Drugs of abuse

Drugs of abuse

Dr B.Vahabi

Drugs of abuse1
Drugs of abuse

Learning outcomes

  • Differentiate between drug use and abuse

  • Identify different classes of drugs

  • Explain the mechanism of action by which different drugs mediate their effects

Drug abuse

Is defined as self-administration of any drug in a manner that differs from approved use in that culture.

A number of therapeutic drugs are abused because of their effects on the nervous system.

The effects of many drugs of abuse are often complicated by the impurity

Drug abuse

Risks associated with drug abuse
Risks associated with drug abuse that differs from approved use in that culture.

  • Acute toxicity

  • Behavioral impact (incapable of concentration, learning or clear thought)

  • Toxic effects of drug contaminants

  • Secondary medical problems such as psychiatric problems

  • Risk of dependency

  • Negative social, occupational, marital consequences.

Drug dependence addiction
Drug dependence/addiction that differs from approved use in that culture.

  • Describes the human condition in which drug taking becomes compulsive

  • State of physical as well as psychological dependence

  • Acute recreational drug use is generally positively reinforcing/rewarding

  • The biological/physiological basis for the reward system lies in the brain

The biological basis of dependence the reward pathway
The biological basis of dependence- the reward pathway that differs from approved use in that culture.

Dependence is related to dopaminergic activity in mesolimbic system of the brain

This system is involved in regulation of mood/ motivation and reward processes

Mesolimbic system is activated by impulses arising from ventral tegmental area of the brain

Impulses are relayed through the medial forebrain bundle via the nucleus accumbens to the prefrontal cortex

Stimulation of postsynaptic D2 dopaminergic receptors activation of Gi (inhibitory) proteins reduction of cAMP levels in nucleus accumbens central to drug seeking behaviour

Chronic adaptations
Chronic adaptations that differs from approved use in that culture.

  • Chronic exposure can cause common adaptations in dopamine function

  • Impaired dopamine system baseline levels of dopamine are reduced

  • Normal rewarding stimuli becomes less effective negative emotional symptoms observed between drug exposures or upon drug withdrawal

  • Chronic drug exposure seems to sensitize the dopamine system

Recreational drugs: that differs from approved use in that culture.

Nicotine, Cannabis

MDMA (Ecstasy)

CNS stimulants:



Drugs of abuse




  • CNS

  • Depressants:

  • Alcohol

  • Benzodiazepines

Cns depressants
CNS depressants that differs from approved use in that culture.

  • Display an inhibitory effect on brain activity

  • Major classes of CNS depressants:

    • Alcohol

    • Benzodiazepines

    • Barbiturates

  • Repeated use results in chronic tolerance, addiction and unpleasant withdrawal symptoms

Alcohol that differs from approved use in that culture.

  • Most frequently abused drug in our society

  • Refers to beverages containing ethyl alcohol or ethanol

  • Infinite solubility in water and slight charge of ethanol allows formation of an equilibrium in the water-rich areas of the body

  • Initial effects: depression of inhibitory neurons relaxation

  • Followed by: Progressive depression of all CNS functions

  • All effects are closely related to blood alcohol concentrations (BAC)

Mechanism of action of alcohol
Mechanism of action of alcohol that differs from approved use in that culture.

  • The main effects are on the CNS

  • The main theories of ethanol action:

    • Enhancement of GABA (gamma-aminobutric acid)-mediated inhibition

    • Inhibition of Ca2+ entry through voltage-gated calcium channels

    • Inhibition of glutamate NMDA (N-methyl-D-asparate) receptor

    • Inhibition of adenosine transport

  • The common neurochemical mechanism of action is via GABAA receptors

Gaba a receptors and alcohol
GABA that differs from approved use in that culture.A receptors and alcohol







Hyperpolarization of the postsynaptic cell

Pyschological effects of alcohol
Pyschological effects of alcohol that differs from approved use in that culture.

  • Depression of circulatory and respiratory processes

  • Human LD50

  • 500

  • Confused

  • Lack of comprehension

  • Possibility of passing out

  • 300

  • Sensory/motor capabilities severely affected

  • Difficulty in focusing (double vision).

  • 200

BAC (mg/100ml)

  • Definite impairment to movement

  • Judgement and perception

  • Severely compromised

  • 150

  • Slowed reaction time

  • Lack of muscle coordination

  • 70-90

  • 30-40

  • Low levels of alcohol can actually improve function on memory tasks.

  • Detectable increase in feeling of well-being and warmth

  • Light-headedness

  • Feeling of happiness

  • Slight exhilaration

  • 10-20

Pyschological effects of alcohol1

Chronic administration causes irreversible neurological effects

May be due to ethanol itself or to metabolites such as acetaldehyde

Heavy drinking causes irreversible dementia and motor impairment associated with thinning of cerebral cortex

Degeneration in the cerebellum and other specific regions can also occur

Alcohol withdrawal symptoms such as delirium tremens and withdrawal fits

Pyschological effects of alcohol



Microsomal oxidase








Cytoplasmic alcohol




Cardiovascular effects of alcohol
Cardiovascular effects of alcohol effects

  • Modest intake (1 unit per day) may have beneficial effects

  • Higher intake has pressor effects: raise blood pressure. Increased risk of coronary artery disease and stroke

  • Cardiac arrhythmias (‘holiday heart’ syndrome) can occur following more chronic abuse

Hepatic effects of alcohol
Hepatic effects of alcohol effects

Hypoglycaemia occurs as a result of the metabolism of alcohol in the liver lactic acidosis

Lactic acidosis facilitates synthesis of saturated fatty acids which accumulate in the liver hepataitis

Malnutrition as a result of chronic alcohol abuse also results in liver damage

The cellular toxicity of ethanol is the main factor promoting inflammatory changes in the liver and cirrhosis

Sexual function and alcohol abuse
Sexual function and alcohol abuse effects

Sexual desire is often increased by alcohol but the ability to sustain penile erection is reduced

Direct damage to Leydig cells of the testis

Reduced testostrone levels


Loss of the male distribution of body hair


Carcinogenesis and teratogenesis
Carcinogenesis and teratogenesis effects

Cancer of the mouth, oesophagus and liver are more common with heavy alcohol use

Risk of colon and breast cancer may also be increased

Fetal alcohol syndrome (FAS):

Abnormal facial development

Reduced cranial circumference

Retarded growth

Mental retardation

FAS affects about 30% of children born to alcoholic mothers

Benzodiazepines bdzs
Benzodiazepines (BDZs) effects

  • The most important group of anxiolytic and hypnotic drugs

  • The first BDZ, chlorodiazepoxide, was synthesized by accident in 1961

  • By mid 1980s there were 17 commercially available BDZs including:

    • Oxazepam

    • Nitrazepam

    • Flurazepam

    • Diazepam

Mechanism of action of bdzs
Mechanism of action of BDZs effects

  • BDZs act selectively on GABAA receptors

  • They increase the affinity of GABAA receptors for GABA

  • Their effect is limited by the amount of neurotransmitter available in the local microenvironment

  • Only effective when GABA-ergic neurons are active


Mechanism of action of bdzs1
Mechanism of action of BDZs effects

The sensitivity to BDZs requires both a & b subunits

Mutations affecting a-subunit may eliminate BDZ action

Experiments on transgenic animals have provided an insight into the role of different a-subunits

Mutations affecting a2-subunit mostly affects anxiolytic action

Mutations affecting a1-subunit mostly affects hypnotic actions

Pharmacological effects of bdzs
Pharmacological effects of BDZs effects

  • The main effects of BDZs are:

    • Reduction of anxiety and aggression

    • Sedation and induction of sleep

    • Reduction of muscle tone and coordination

    • Anticonvulsant effect

What is anxiety
What is anxiety? effects

  • In Western world diagnosis of anxiety disorders comprise around 5-10% of psychiatrically diagnosed diseases

Unwanted effects of bdzs
Unwanted effects of BDZs effects

  • Divided to:

  • Toxic effects from acute overdose

  • Unwanted side effects during normal therapeutic dose

  • Tolerance and dependence

Acute toxicity
Acute toxicity effects

  • Less dangerous than other anxiolytic/hypnotic drugs

  • Overdose causes prolonged sleep without serious depression of respiration or cardiovascular function

  • However, in the presence of other CNS depressants (e.g. alcohol) can cause life threatening respiratory depression

  • Availability of an effective antagonist, flumazenil, allows for the acute overdose to be counteracted

Side effects during therapeutic use
Side effects during therapeutic use effects

  • The main side effects are:

    • Drowsiness

    • Confusion

    • Amnesia

    • Impaired coordination

  • BDZs enhance the depressant effect of other drugs such as alcohol

  • Tolerance and dependency
    Tolerance and dependency effects

    • Tolerance occurs with BDZs

    • Dependence also occurs with all BDZs

    • Addiction is not a major problem

    • Stopping BDZs after weeks/months causes an increase in symptoms of anxiety

    • Withdrawl symptoms include:

      • Tremor

      • Dizziness

      • Nervousness

      • Loss of appetite

      • Convulsions

    Barbiturates effects

    • Are far more depressant than BZDs

    • Produce effects similar to inhalation of anaesthetics

    • The first barbiturate , barbituric acid was synthesized in 1846

    • Only a few barbiturates are now used for clinical purposes due to adverse side effects

    Mechanism of action of barbiturates
    Mechanism of action of barbiturates effects

    • Directly open GABAA receptor Cl- channel in the absence of endogenous neurotransmitters

    • They stabilise the membrane at its resting potential rendering it unresponsive to physiological or electrical stimuli

    Pharmacological clinical effects of barbiturates
    Pharmacological/clinical effects of barbiturates effects

    • Low doses have euphoric/stimulant effect

    • Higher doses have hypnotic/anxiolytic effect

    Adverse effects

    • Overdosage can cause respiratory slowing and death

    • Dangerous effects if taken with other drugs such as alcohol

    Recreational drugs: effects

    Nicotine, Cannabis

    MDMA (Ecstasy)

    CNS stimulants:



    Drugs of abuse




    • CNS

    • Depressants:

    • Alcohol

    • Benzodiazepines

    Key references
    Key references effects

    • Parrott, A et al (2007) Drugs and behaviour. John Wiley & Sons Ltd.

    • Rang, H.P., Dale, M.M. (2007) Pharmacology. 6th ed. Churchill Livingstone.

    • Waller, D.G. et al (2007) Medical pharmacology and therapeutics. 2nd ed. Elsevier Saunders.

    • Nestler, E.J. (2005) Is there a common molecular pathway for addiction. Nature Neurosience. 8:1445-1449

    • Kreek, M.J. & Koob, G.F. ( 1998) Drug dependence: stress and dysregualtion of brain reward pathways. Drug & Alcohol dependence. 51: 23-47

    • Pierce, R.C. & Kumaresan, V. (2006) The mesolimbic dopamine system: The final common pathway for reinforcing effect of drug abuse. Neuroscience & Biobehavioral Reviews. 30: 215-238

    • Thomas, J.D & Riley, E.P. (1998) Fetal alcohol syndrome. Does alcohol withdrawal play a role? Alcohol Health and Research World. 22:47-53